Technology News and Research

RSS

Baxter Healthcare presents phase I inhaled insulin study results

Baxter Healthcare Corporation announced results of a Phase I study that evaluated pulmonary insulin produced with Baxter's PROMAXX microsphere technology and administered using a small, standard dry powder inhaler.

24 Apr 2007

Community based digital eye screening programme set to expand

Community based digital eye screening programme designed to detect and treat diabetic retinopathy, the leading cause of blindness in the developed world, is being rolled out to other locations, following its huge success since launching seven months ago.

24 Apr 2007

Johns Hopkins creates database of phosphorylation events

Researchers at Johns Hopkins took advantage of a new technique that reads the makeup of proteins to identify nearly all chemical changes nature makes by adding phosphate to proteins manufactured in human cells.

24 Apr 2007

Discovery of new virus

Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and 454 Life Sciences have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia.

24 Apr 2007

Novadaq Technologies acquires fluorescence endoscopy patents from Xillix

Novadaq Technologies Inc. has announced that it has entered into an asset purchase agreement to acquire certain business assets of Xillix Technologies Corp., including all of Xillix's intellectual property, certain capital assets and inventory.

24 Apr 2007

NanoFrontiers: Visions for the Future of Nanotechnology

Controlling the properties and behavior of matter at the smallest scale, in effect, "domesticating atoms",can help to overcome some of the world's biggest challenges, concludes a new report on how diverse experts view the future of nanotechnology.

24 Apr 2007

FDA approves generic versions of Ambien

The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.

24 Apr 2007

BioForce Nanosciences sells Nano Enabler to Louisiana Tech

BioForce Nanosciences has announced the March sale of the Nano eNabler molecular printer to Louisiana Tech University in Ruston, Louisiana.

24 Apr 2007

Banning sweets from school lunches helps to combat childhood obesity

Nutritious school lunches and a ban on sweets, buns and sweetened drinks in school is a good strategy for reducing the risk of obesity in children, reveals a new study from Swedish medical university Karolinska Institutet.

24 Apr 2007

Avicena files composition of matter patent application for treatment of Lou Gehrig's disease

Avicena Group has announced that it has filed a composition of matter patent application with the United States Patent and Trademark Office for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease), a severe neurodegenerative disease.

24 Apr 2007

Developing world can expect a 'pandemic of cancer' by 2020

The developing world is expected to account for more than half of all cancer cases in the world by 2020 say medical experts.

23 Apr 2007

University of Delaware scientist wins NSF career award for tissue engineering

Xinqiao Jia will never forget a visitor to her professor's lab at Fudan University in Shanghai, China, when she was working on her master's degree in polymer chemistry and physics.

21 Apr 2007

Discovery of important clue to the susceptibility of individuals to Crohn's disease

Crohn's disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. Common symptoms include abdominal pain and diarrhea, but the disorder is often associated with debilitating clinical complications.

21 Apr 2007

ZARS announces Swedish marketing approval for Rapydan

ZARS, Inc. has announced that the Medical Products Agency in Sweden has approved Rapydan 70 mg/70 mg medicated plaster, a topical local anesthetic patch.

20 Apr 2007

Risk and outcome similar for bypass surgery, drug-eluting stents

Drug-eluting stent therapy and bypass surgery for coronary artery disease have about the same risk for a major cardiac event within 30 days after the procedures, researchers reported at the American Heart Association's 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology.

20 Apr 2007

Autonomy Laparo-angle instrumentation from Cambridge Endo

Cambridge Endo, a Massachusetts-based medical device company, has announced the development of the first full-line of fully articulating hand-held instruments for laparoscopic surgeons: Autonomy Laparo-Angle Instrumentation.

20 Apr 2007

Vasogen and Grupo Ferrer to commercialize Celacade in Europe

Vasogen has announced a collaboration with Grupo Ferrer Internacional, S.A. ("Ferrer"), to commercialize Vasogen's Celacade technology for the treatment of chronic heart failure in the European Union and in certain Latin American countries.

19 Apr 2007

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

19 Apr 2007

Micell Technologies presents data on novel drug-eluting stents

Micell Technologies has announced that the Company will be presenting data on use of its supercritical fluid (SCF) surface modification technology for drug-eluting stents at the upcoming Society for Biomaterials 2007 Annual Meeting, April 19-21 2007 in Chicago, Illinois.

19 Apr 2007

Lexicon-Genentech reveals potential therapeutic targets

Lexicon Genetics Incorporated has announced that data was presented highlighting potential therapeutic targets related to its collaboration with Genentech, Inc. at the Society for Biomolecular Sciences 13th Annual Conference & Exhibition in Montreal, Canada.

19 Apr 2007